What is Synecor?
Synecor, LLC operates as a dedicated accelerator for novel cardiovascular research, devices, and development ventures. With operational hubs in Menlo Park, California, and Research Triangle Park, North Carolina, the company is strategically positioned to foster innovation in the biomedical and healthcare sectors. Its focus on early-stage companies aims to bridge the gap between groundbreaking ideas and market-ready solutions, contributing to the advancement of cardiovascular health.
How much funding has Synecor raised?
Synecor has raised a total of $1.5M across 1 funding round:
Angel/Seed
$1.5M
Angel/Seed (2000): $1.5M, investors not publicly disclosed
What's next for Synecor?
The substantial enterprise-level funding indicates Synecor is likely in a growth or scaling phase, poised to expand its accelerator programs and invest in a broader portfolio of promising cardiovascular technologies. This strategic capital infusion is expected to accelerate the development and commercialization of new devices and research initiatives, solidifying Synecor's position as a key player in the cardiovascular innovation ecosystem.
See full Synecor company page
